All Stories

  1. Combined serum (1,3)-β-D-Glucan and Oral Wash PCR as a non-invasive diagnostic strategy for early detection of Pneumocystis jirovecii pneumonia: an observational retrospective study

    Article • Open Forum Infectious Diseases, January 2026, Oxford University Press (OUP)

    Mr Ibai Los-Arcos

  2. Utility of the ELISpot Test to Predict the Risk of Developing BK Polyomavirus Nephropathy in Kidney Recipients, a Multicenter Study

    Article • Vaccines, July 2025, MDPI AG

    Mr Ibai Los-Arcos

  3. ORCHESTRA Delphi consensus: diagnostic and therapeutic management of SARS-CoV-2 infection in solid organ transplant recipients

    Article • Clinical Microbiology and Infection, June 2025, Elsevier

    Mr Ibai Los-Arcos

  4. Correction: Kirkegaard-Biosca et al. Cefiderocol for the Treatment of Infections by VIM-Type-Producing Gram-Negative Bacteria. Antibiotics 2024, 13, 874

    Article • Antibiotics, December 2024, MDPI AG

    Mr Ibai Los-Arcos

  5. Management of cytomegalovirus in adult solid organ transplant patients: GESITRA-IC-SEIMC, CIBERINFEC, and SET recommendations update

    Article • Transplantation Reviews, December 2024, Elsevier

    Mr Ibai Los-Arcos

  6. Ciprofloxacin for the Treatment of Infections Caused by Carbapenemase-Producing Gram-Negative Bacteria

    Article • Antibiotics, November 2024, MDPI AG

    Mr Ibai Los-Arcos

  7. Role of SARS-CoV-2-specific memory B cells promoting immune protection after booster vaccination in solid organ transplantation

    Article • Frontiers in Immunology, October 2024, Frontiers

    Mr Ibai Los-Arcos

  8. Cefiderocol for the Treatment of Infections by VIM-Type-Producing Gram-Negative Bacteria

    Article • Antibiotics, September 2024, MDPI AG

    Mr Ibai Los-Arcos

  9. Article • Experimental and Clinical Transplantation, August 2024, Baskent University

    Mr Ibai Los-Arcos

  10. Patients with aggressive B‐cell lymphoma receiving CAR T‐cell therapy have a low rate of severe infections despite lack of universal antibacterial and antifungal prophylaxis

    Article • European Journal Of Haematology, April 2024, Wiley

    Mr Ibai Los-Arcos

  11. Tobramycin Systemic Absorption in Lung Transplant Recipients Treated With Inhaled Tobramycin: A Cohort Study

    Article • Transplant International, March 2024, Frontiers

    Mr Ibai Los-Arcos

  12. Effect of SARS‐CoV‐2 preventive measures on early lung transplant fungal acquisition: An observational study

    Article • Transplant Infectious Disease, January 2024, Wiley

    Mr Ibai Los-Arcos

  13. Executive summary of the consensus statement of the group for the study of infection in transplantation and other immunocompromised host (GESITRA-IC) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) on the treatment of SA...

    Article • Transplantation Reviews, December 2023, Elsevier

    Mr Ibai Los-Arcos

  14. Oral fosfomycin for treatment of acute bacterial prostatitis caused by multidrug-resistant Enterobacterales

    Article • Microbiology Spectrum, October 2023, ASM Journals

    Mr Ibai Los-Arcos

  15. Impact of Prophylactic Norfloxacin in Multidrug Resistant Bacterial Infections in the Early Liver Posttransplant Period

    Article • Experimental and Clinical Transplantation, March 2023, Baskent University

    Mr Ibai Los-Arcos

  16. Transplantation of organs from SARS‐CoV‐2‐positive donors: Preliminary experience from Spain

    Article • Transplant Infectious Disease, January 2023, Wiley

    Mr Ibai Los-Arcos

  17. Osteosynthesis-associated infection of the lower limbs by multidrug-resistant and extensively drug-resistant Gram-negative bacteria: a multicentre cohort study

    Article • Journal of Bone and Joint Infection, December 2022, Copernicus GmbH

    Mr Ibai Los-Arcos

  18. Impact of Cytomegalovirus Replication in Patients with Aggressive B Cell Lymphoma Treated with Chimeric Antigen Receptor T Cell Therapy

    Article • Transplantation and Cellular Therapy, December 2022, Elsevier

    Mr Ibai Los-Arcos

  19. Ceftazidime-Avibactam plus Aztreonam for the Treatment of Infections by VIM-Type-Producing Gram-Negative Bacteria

    Article • Antimicrobial Agents and Chemotherapy, October 2022, ASM Journals

    Mr Ibai Los-Arcos

  20. Preliminary Clinical Experience of Molnupiravir to Prevent Progression of COVID-19 in Kidney Transplant Recipients

    Article • Transplantation, August 2022, Wolters Kluwer Health

    Mr Ibai Los-Arcos

  21. Assessment of Quantiferon®-CMV and Immuknow® Assays in CMV-seropositive Lung Transplant Recipients to Stratify Risk of CMV Infection

    Article • Archivos de Bronconeumología (English Edition), August 2022, Elsevier

    Dr Pedro J Marcos, Mr Ibai Los-Arcos

  22. Nosocomial COVID-19. Prospective study in a referral hospital

    Article • Medicina Clínica (English Edition), August 2022, Elsevier

    Mr Ibai Los-Arcos

  23. COVID-19 nosocomial. Estudio prospectivo en un hospital de referencia

    Article • Medicina Clínica, August 2022, Elsevier

    Mr Ibai Los-Arcos

  24. Positive Polymerase Chain Reaction for SARS-CoV-2 in a Candidate Does Not Always Preclude Liver Transplantation: Case Report and Literature Review

    Article • Experimental and Clinical Transplantation, March 2022, Baskent University

    Mr Ibai Los-Arcos

  25. Safety and Effectiveness of Isavuconazole Treatment for Fungal Infections in Solid Organ Transplant Recipients (ISASOT Study)

    Article • Microbiology Spectrum, February 2022, ASM Journals

    Mr Ibai Los-Arcos

  26. Impact of ceftazidime/avibactam versus best available therapy on mortality from infections caused by carbapenemase-producing Enterobacterales (CAVICOR study)

    Article • Journal of Antimicrobial Chemotherapy, February 2022, Oxford University Press (OUP)

    Jordi Carratalà, Mr Ibai Los-Arcos

  27. Predictive Value of Immune Cell Functional Assay for Non-Cytomegalovirus Infection in Lung Transplant Recipients: A Multicenter Prospective Observational Study

    Article • Archivos de Bronconeumología (English Edition), November 2021, Elsevier

    Dr Pedro J Marcos, Mr Ibai Los-Arcos

  28. Predictive Value of Immune Cell Functional Assay for Non-Cytomegalovirus Infection in Lung Transplant Recipients: A Multicenter Prospective Observational Study

    Article • Archivos de Bronconeumología (English Edition), November 2021, Elsevier

    Dr Pedro J Marcos, Mr Ibai Los-Arcos

  29. Low seroprevalence of SARS‐CoV‐2 antibodies in a liver transplant cohort

    Article • Transplant International, July 2021, Frontiers

    Mr Ibai Los-Arcos

  30. Long‐term effects of COVID‐19 in solid organ transplantation recipients

    Article • Transplant Infectious Disease, July 2021, Wiley

    Mr Ibai Los-Arcos

  31. Immunoguided Discontinuation of Prophylaxis for Cytomegalovirus Disease in Kidney Transplant Recipients Treated With Antithymocyte Globulin: A Randomized Clinical Trial

    Article • Clinical Infectious Diseases, June 2021, Oxford University Press (OUP)

    Mr Ibai Los-Arcos

  32. Nebulized Micafungin Treatment for Scopulariopsis / Microascus Tracheobronchitis in Lung Transplant Recipients

    Article • Antimicrobial Agents and Chemotherapy, May 2021, ASM Journals

    Mr Ibai Los-Arcos

  33. Does Routine Abdominal Drain Tip Culture Anticipate Post-Operative Infection in Liver Transplantation?

    Article • Surgical Infections, March 2021, Mary Ann Liebert Inc

    Mr Ibai Los-Arcos

  34. CMV-Specific Cell-Mediated Immunity Predicts a High Level of CMV Replication After Prophylaxis Withdrawal in Lung Transplant Recipients

    Article • The Journal of Infectious Diseases, November 2020, Oxford University Press (OUP)

    Mr Ibai Los-Arcos

  35. COVID‐19 in lung transplant recipients: A multicenter study

    Article • Arabian archaeology and epigraphy, November 2020, Wiley

    Mr Ibai Los-Arcos

  36. Executive summary of the Consensus Statement of the Transplant Infection Study Group (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the National Transplant Organization (ONT) on the Selection Criteria of D...

    Article • Enfermedades Infecciosas y Microbiología Clínica, October 2020, Elsevier

    Jordi Carratalà, Mr Ibai Los-Arcos

  37. Recommendations for screening, monitoring, prevention, and prophylaxis of infections in adult and pediatric patients receiving CAR T-cell therapy: a position paper

    Article • Infection, September 2020, Springer Science + Business Media

    Mr Ibai Los-Arcos

  38. COVID-19 in Solid Organ Transplantation: A Matched Retrospective Cohort Study and Evaluation of Immunosuppression Management

    Article • Transplantation, September 2020, Wolters Kluwer Health

    Mr Ibai Los-Arcos

  39. Routine Bile Culture From Liver Donors as Screening of Donor‐Transmitted Infections in Liver Transplantation

    Article • Liver Transplantation, August 2020, Wolters Kluwer Health

    Mr Ibai Los-Arcos

  40. A new pleosporalean fungus isolated from superficial to deep human clinical specimens

    Article • Medical Mycology, July 2020, Oxford University Press (OUP)

    Mr Ibai Los-Arcos

  41. Nuevos antibióticos para el tratamiento de las infecciones por microorganismos multirresistentes

    Article • Medicina Clínica, May 2020, Elsevier

    Mr Ibai Los-Arcos

  42. Selection criteria of solid organ donors in relation to infectious diseases: A Spanish consensus

    Article • Transplantation Reviews, April 2020, Elsevier

    Mr Ibai Los-Arcos

  43. An overview of ceftolozane sulfate + tazobactam for treating hospital acquired pneumonia

    Article • Expert Opinion on Pharmacotherapy, March 2020, Taylor & Francis

    Mr Ibai Los-Arcos

  44. Donor-derived bacterial infections in lung transplant recipients in the era of multidrug resistance

    Article • Journal of Infection, February 2020, Elsevier

    Mr Ibai Los-Arcos

  45. Riesgo de infección asociado a nuevas terapias para el tratamiento de los síndromes linfoproliferativos

    Article • Medicina Clínica, November 2019, Elsevier

    Mr Ibai Los-Arcos

  46. Effects of the extracorporeal membrane oxygenation circuit on plasma levels of ceftolozane

    Article • Perfusion, August 2019, SAGE Publications

    Mr Ibai Los-Arcos

  47. Antibiotic Treatment Versus No Treatment for Asymptomatic Bacteriuria in Kidney Transplant Recipients: A Multicenter Randomized Trial

    Article • Open Forum Infectious Diseases, May 2019, Oxford University Press (OUP)

    Jordi Carratalà, Mr Ibai Los-Arcos

  48. Phaeohyphomycosis caused by Medicopsis romeroi in solid organ transplant recipients: Report of two cases and comprehensive review of the literature

    Article • Transplant Infectious Disease, March 2019, Wiley

    Mr Ibai Los-Arcos

  49. Infections by OXA-48-like-producing Klebsiella pneumoniae non-co-producing extended spectrum beta-lactamase: can they be treated successfully with cephalosporins?

    Article • Journal of Global Antimicrobial Resistance, February 2019, Elsevier

    Mr Ibai Los-Arcos

  50. Prognostic factors in 264 adults with invasive Scedosporium spp. and Lomentospora prolificans infection reported in the literature and FungiScope®

    Article • Critical Reviews in Microbiology, January 2019, Taylor & Francis

    Mr Ibai Los-Arcos, Dr Axel G Hamprecht

  51. Is antibody-mediated rejection in kidney transplant recipients a risk factor for developing cytomegalovirus or BK virus infection? Results from a case-control study

    Article • Journal of Clinical Virology, January 2019, Elsevier

    Mr Ibai Los-Arcos

  52. Lung transplantation in two cystic fibrosis patients infected with previously pandrug-resistant Burkholderia cepacia complex treated with ceftazidime–avibactam

    Article • Infection, December 2018, Springer Science + Business Media

    Mr Ibai Los-Arcos

  53. Community-acquired respiratory viruses are a risk factor for chronic lung allograft dysfunction

    Article • Clinical Infectious Diseases, December 2018, Oxford University Press (OUP)

    Mr Ibai Los-Arcos

  54. Clinical Characteristics and Outcome of Lung Transplant Recipients with Respiratory Isolation ofCorynebacteriumspp.

    Article • Journal of Clinical Microbiology, May 2018, ASM Journals

    Mr Ibai Los-Arcos

  55. Ceftolozane/tazobactam for the treatment of XDR Pseudomonas aeruginosa infections

    Article • Infection, March 2018, Springer Science + Business Media

    Mr Ibai Los-Arcos

  56. Prevalence of Chagas Disease among Solid Organ–Transplanted Patients in a Nonendemic Country

    Article • American Journal of Tropical Medicine and Hygiene, March 2018, American Society of Tropical Medicine and Hygiene

    Mr Ibai Los-Arcos

  57. Case Report: Successful Lung Transplantation from a Donor Seropositive for Trypanosoma cruzi Infection (Chagas Disease) to a Seronegative Recipient

    Article • American Journal of Tropical Medicine and Hygiene, October 2017, American Society of Tropical Medicine and Hygiene

    Mr Ibai Los-Arcos

  58. Successful liver transplantation despite donor-transmitted ESBL-producing Klebsiella pneumoniae infection: Case report and review of the literature

    Article • Transplant Infectious Disease, August 2017, Wiley

    Mr Ibai Los-Arcos

  59. Executive summary of the diagnosis and treatment of urinary tract infection: Guidelines of the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC)

    Article • Enfermedades infecciosas y microbiologia clinica (English ed ), May 2017, Elsevier

    Mr Ibai Los-Arcos

  60. Executive summary of the diagnosis and treatment of urinary tract infection: Guidelines of the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC)

    Article • Enfermedades Infecciosas y Microbiología Clínica, May 2017, Elsevier

    Mr Ibai Los-Arcos

  61. Reply to “Activity of Fosfomycin on Clinical Isolates of Campylobacter jejuni and Campylobacter coli of Enteric Origin”

    Article • Antimicrobial Agents and Chemotherapy, January 2017, ASM Journals

    Mr Ibai Los-Arcos

  62. Determination of neutrophil CD64 expression as a prognostic biomarker in patients with community-acquired pneumonia

    Article • European Journal of Clinical Microbiology & Infectious Diseases, May 2016, Springer Science + Business Media

    Mr Ibai Los-Arcos

  63. Fosfomycin for Recurrent Campylobacter

    Article • Antimicrobial Agents and Chemotherapy, May 2016, ASM Journals

    Mr Ibai Los-Arcos, Juan Aguilar-Company

  64. Long-Term Fosfomycin-Tromethamine Oral Therapy for Difficult-To-Treat Chronic Bacterial Prostatitis

    Article • Antimicrobial Agents and Chemotherapy, December 2015, ASM Journals

    Mr Ibai Los-Arcos

  65. Epidemiology and Diagnosis of Tuberculous Lymphadenitis

    Article • Medicine, January 2015, Wolters Kluwer Health

    Mr Ibai Los-Arcos

  66. Reply

    Article • Arthritis Care & Research, May 2014, Wiley

    Mr Ibai Los-Arcos

  67. A 72-Year-Old Man With Dyspnea, Circumferential Aortic Thickening, and Weight Loss

    Article • Arthritis Care & Research, November 2013, Wiley

    Mr Ibai Los-Arcos